|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.52 USD | -2.43% |
|
-1.96% | +78.09% |
| 05/03 | Berenberg Raises Price Target on Moderna to $45 From $32, Keeps Hold Rating | MT |
| 05/03 | US stocks close up on Iran diplomacy hopes; tech leads rebound | RE |
Main competitors
| Revenues (N-1) | Net Margin (N-1) | EBIT Margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
|---|---|---|---|---|---|---|---|
| 194.4Cr | -145.16% | -158.13% | -28.87% | -21.31% | 2.03x | ||
| 1.43TCr | 31.41% | 34.05% | 16.13% | 12.48% | -1.09x | ||
| 908.89Cr | 20.13% | 25.95% | 14.03% | 6.99% | 0.16x | ||
| 315.68Cr | 39.16% | 45.41% | 17.59% | 9.45% | -0.54x | ||
| 1.56TCr | 19.3% | 28.72% | 16.36% | 7.75% | 1.74x | ||
| 989.06Cr | 13.07% | 28.69% | 7.39% | 4.5% | 0.68x | ||
| 514.12Cr | 25.03% | 31.43% | 31.7% | 22.02% | -1.81x | ||
| 129.08Cr | -1% | -8.02% | -0.74% | -0.45% | -11.4x | ||
| 235.17Cr | 14.93% | 22.42% | 10.9% | 5.41% | 1.59x | ||
| 6.96Cr | 59.01% | 24.7% | 28.77% | 18.72% | -6.16x | ||
| 50Cr | -144.39% | -104.25% | - | -91.4% | -2.36x | ||
| 322.13Cr | 10.83% | 12.71% | 8.54% | 5.8% | -2.91x | ||
| 64Cr | -28.69% | -26.12% | -252.11% | -29.11% | 0.85x | ||
| 39Cr | 52.64% | 41.45% | 18.91% | - | - | ||
| 31Cr | 4.73% | 4.18% | 0.85% | - | -5.29x | ||
| 883.43Cr | 5.34% | 18.49% | 7.86% | 2.36% | 4.81x | ||
| 124.78Cr | 22.95% | 28.06% | 14.19% | 8.74% | 0.28x | ||
| 112.02Cr | 26.82% | 32.8% | 7.13% | 6.69% | -1.03x | ||
| 357.16Cr | 7.74% | 8.68% | 6.46% | 4.03% | 3.63x | ||
| Average | 435.09Cr | 1.78% | 4.8% | -4.16% | -1.61% | -0.93x | |
| Weighted average by Cap. | 754.77Cr | 10.03% | 14.18% | 7.03% | 3.59% | -0.74x |
- Stock Market
- Equities
- MRNA Stock
- Sector Moderna, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















